Persistent polyagglutinability in vivo unrelated to T-anigen activation.
D000017:ABO Blood-Group System; D000042:Absorption; D000469:Alkaline Phosphatase / Q000097:blood; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000941:Antigens; D001803:Blood Transfusion; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D002859:Chromium Isotopes; D004905:Erythrocyte Aging; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology*; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006384:Hemagglutination; D006386:Hemagglutination Tests; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D007970:Leukopenia / Q000097:blood; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology; D009439:Neuraminidase / Q000494:pharmacology; D010504:Periodic Acid / Q000494:pharmacology; D013154:Spleen / Q000473:pathology; D013156:Splenectomy; D013696:Temperature; D013921:Thrombocytopenia / Q000097:blood / Q000188:drug therapy
D000017:ABO Blood-Group System; D000888:Antibodies, Anti-Idiotypic; D000941:Antigens; D002859:Chromium Isotopes; D037102:Lectins; D010504:Periodic Acid; D015122:Mercaptopurine; D000469:Alkaline Phosphatase; D009439:Neuraminidase